This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Oral Controlled Release Drug Delivery Technology Market

Market Insights on Oral Controlled Release Drug Delivery Technology covering sales outlook, demand forecast & up-to-date key trends

Oral Controlled Release Drug Delivery Technology Market By Dosage Form (Solid Dosage Forms, Semisolid, Liquid/Suspension), Drug Release System (Diffusion Controlled Release System, Dissolution Controlled Release System, Osmotically Controlled Release System) & Region - Forecast 2017 - 2027

Large-scale requirement of anti-hypertensive drugs and higher adoption of combination approaches drive the global oral controlled release drug delivery technology market

Oral control release drug delivery system provides high therapeutic efficiency, improved stability of drug, etc. As oral controlled release drug are cost effective, lowers the minimum dosage requirement and also lesser side effects are helping the sector in its lucrative growth. Prominent players in the sector include Bracco Group, Nemoto Kyorindo Co., Ltd., Sino Medical Device Technology Co., Ltd., Vivid Imaging, Guerbet Group, Medtron AG, Bayer HealthCare LLC, Ulrich GmbH & Co., Apollo RT Co. Ltd., Corium International Inc., Pfizer, Inc., Biogen, Glaxo Smith Kline, Novartis, Corium International, inc., Alza Corporation, etc. Development during the covd-19 pandemic and after it are helping the manufacturers to stabilise their position in the market.

There has been research regarding micro and nano-scale technologies in oral drug delivery. In the article published by ncbi.nlm.nih.gov, micro and nano scale technologies can create, control and measure micro environments. The nano and micro technology in drug discovery can be used in development of high throughput screening assays, miniaturization of therapeutic and diagnostic tools, tissue engineering and, oral drug delivery. These technologies help in sensing, recording and stimulating biological systems by fabrication techniques for optimised drug delivery.

3D printing technology has been an emerging technology on the design and manufacture of pharmaceutical oral formulation. As per the research Journal of Basic and Applied Sciences, 3D printing technique can be used to produce tailored doses of drug products at small scale. 3D printing can be an attractive research and development opportunity to improve drug formulation. With the help of 3D printing technology, the manufacturers are able to design and produce novel complex drug products and multiple active drug pharmaceutical ingredients into one dosage form with customised release trends.

In June 2020, Evonik launched a Resomer Precise custom and sophisticated technology to enable process validation of polymers to tight specifications in parental drugs. The platform enables pharmaceutical companies to control the release profile of parenteral drug products with a high level of accuracy and precision. Resomer precise aims to deliver significant value to pharmaceutical companies satisfying regulatory authorities.

The increase in generic drug consumption is driven by rising access to healthcare facilities and is fuelling the need for faster availability of drugs in oral solid dosages. This in turn fuels the need for application of controlled release technology, which could increase the availability of the drugs in reduced dosages.

Further, with many big drug makers establishing a local manufacturing presence across various regions, the adoption of controlled release technology is expected to witness a growing spiral in the coming years especially in countries such as Brazil, Argentina, Costa Rica and Mexico.

The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes. This helps in better pricing and rapid time to market for the otherwise unviable products in the short run. A higher adoption of combination approaches is expected to boost the global market for oral controlled release drug delivery technology.

Increasing approvals of modified and extended release oral dosage forms by PMDA is likely to drive the growth in revenue of the Japan oral controlled release drug delivery technology market. In the case of new approvals, high preference towards tablets and capsules has been observed, as formulation scientists find it easy to create formulations for clinical as well as therapeutic use.

 Moreover, when compared to western countries such as the U.S. and Germany, Japan offers greater variety in the choice of oral solid dosage forms due to increased accessibility to local formulations.

Large-scale requirement of anti-hypertensive drugs are likely to boost the market growth to a great extent. The large-scale requirement of anti-hypertensive drugs is fuelling the need for more companies to set up plants deploying controlled release technologies. The requirement is more for technology adoption of OROS and SODAS. Indigenous development of pharmaceutical infrastructure is a very important factor expected to fuel revenue growth of the oral controlled release drug delivery technology market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Diffusion and Dissolution are the most preferred controlled release systems, representing a lucrative market opportunity for manufacturers of oral controlled release drug delivery technologies

The Dissolution Controlled Release System segment dominated the global oral controlled release drug delivery technology market in terms of revenue in 2017, and the trend is projected to continue throughout the forecast period. Dissolution Controlled Release System is the most attractive segment, with an attractiveness index of 3.6 over the forecast period. This segment accounted for close to 45% value share in 2017 and is projected to hold about 50% share by 2027 end.

Oral Controlled Release Drug Delivery Technology Market Download Report Brochure

The Others segment, which includes upcoming technologies such as nanotechnology and other advanced matrix technologies is also growing at an exponential rate in terms of revenue in 2017 and the trend is projected to sustain throughout the forecast period. The Others segment is the most attractive segment, with a market attractiveness index of 0.6 over the forecast period.

Controlled Release Formulations – A common strategy to extend the product life cycle

Controlled Release is the most common strategy adopted by pharma giants across the globe to extend the product life cycle. Modified or controlled release formulations of pre-approved drugs are enjoying extended market exclusivity. The introduction of proprietary prescribed medicines in controlled release forms will help drive revenue growth of the global market.

Other release mechanisms include enteric release, such as those used in enteric softgel capsules, osmotically active release, effervescent and sublingual release. OROS (Johnson & Johnson and Alza Corporation) and SODAS (Elan Technologies) are the most commercialised technologies in the oral controlled release drug delivery technology market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Market Taxonomy

By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

By Drug Release System :

  • Diffusion Controlled Release System
  • Dissolution Controlled Release System
  • Osmotically Controlled Release System
  • Dissolution & Diffusion Controlled Release System
  • Ion Exchange Resins Controlled Release
  • Hydro-dynamically Balanced Drug Delivery System
  • Others

By Dosage Form :

  • Solid Dosage Forms
  • Semisolid
  • Liquid/Suspension
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Frequently Asked Questions

The global oral controlled release drug delivery technology market is expected to secure a market value of US$ 128.4 billion by 2032

The global oral controlled release drug delivery technology market is anticipated to display a CAGR of 10.48% during the forecast period from 2022 to 2032

The known players in the global oral controlled release drug delivery technology market include Coating Place, Inc., Pfizer, Inc., and Capsugel, among others.

Table of Content

Table of Content

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Oral Controlled Release Drug Delivery Technology Market Opportunity Analysis 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Trends

3.4. Recent advancements in Oral Controlled Release Drug Delivery Technology

4. North America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

4.5.1. Diffusion Controlled Release System

4.5.2. Dissolution Controlled Release System

4.5.3. Osmotically Controlled Release System

4.5.4. Dissolution & Diffusion Controlled Release System

4.5.5. Ion Exchange Resins Controlled Release

4.5.6. Hydro-dynamically balanced drug delivery system

4.5.7. Others

4.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

4.6.1. Diffusion Controlled Release System

4.6.2. Dissolution Controlled Release System

4.6.3. Osmotically Controlled Release System

4.6.4. Dissolution & Diffusion Controlled Release System

4.6.5. Ion Exchange Resins Controlled Release

4.6.6. Hydro-dynamically balanced drug delivery system

4.6.7. Others

4.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

4.7.1. Solid Dosage Forms

4.7.2. Semisolid/Liquid/ Suspensions

4.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

4.8.1. Solid Dosage Forms

4.8.2. Semisolid/Liquid/ Suspension

4.9. Market Attractiveness Analysis

4.9.1. By Country

4.9.2. By Drug Release System

4.9.3. By Dosage Form

4.10.Key Representative Market Participants

4.11.Market Presence (Intensity Map)

4.12.Forecast Impact Factors

5. Latin America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

5.5.1. Diffusion Controlled Release System

5.5.2. Dissolution Controlled Release System

5.5.3. Osmotically Controlled Release System

5.5.4. Dissolution & Diffusion Controlled Release System

5.5.5. Ion Exchange Resins Controlled Release

5.5.6. Hydro-dynamically balanced drug delivery system

5.5.7. Others

5.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

5.6.1. Diffusion Controlled Release System

5.6.2. Dissolution Controlled Release System

5.6.3. Osmotically Controlled Release System

5.6.4. Dissolution & Diffusion Controlled Release System

5.6.5. Ion Exchange Resins Controlled Release

5.6.6. Hydro-dynamically balanced drug delivery system

5.6.7. Others

5.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

5.7.1. Solid Dosage Forms

5.7.2. Semisolid/Liquid/ Suspensions

5.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

5.8.1. Solid Dosage Forms

5.8.2. Semisolid/Liquid/ Suspension

5.9. Market Attractiveness Analysis

5.9.1. By Country

5.9.2. By Drug Release System

5.9.3. By Dosage Form

5.10.Key Representative Market Participants

5.11.Market Presence (Intensity Map)

5.12.Forecast Impact Factors

6. Western Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

6.3.1. Germany

6.3.2. Italy

6.3.3. France

6.3.4. Spain

6.3.5. U.K.

6.3.6. Nordic

6.3.7. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.4.1. Germany

6.4.2. Italy

6.4.3. France

6.4.4. Spain

6.4.5. U.K.

6.4.6. Nordic

6.4.7. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

6.5.1. Diffusion Controlled Release System

6.5.2. Dissolution Controlled Release System

6.5.3. Osmotically Controlled Release System

6.5.4. Dissolution & Diffusion Controlled Release System

6.5.5. Ion Exchange Resins Controlled Release

6.5.6. Hydro-dynamically balanced drug delivery system

6.5.7. Others

6.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

6.6.1. Diffusion Controlled Release System

6.6.2. Dissolution Controlled Release System

6.6.3. Osmotically Controlled Release System

6.6.4. Dissolution & Diffusion Controlled Release System

6.6.5. Ion Exchange Resins Controlled Release

6.6.6. Hydro-dynamically balanced drug delivery system

6.6.7. Others

6.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

6.7.1. Solid Dosage Forms

6.7.2. Semisolid/Liquid/ Suspensions

6.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

6.8.1. Solid Dosage Forms

6.8.2. Semisolid/Liquid/ Suspension

6.9. Market Attractiveness Analysis

6.9.1. By Country

6.9.2. By Drug Release System

6.9.3. By Dosage Form

6.10.Key Representative Market Participants

6.11.Market Presence (Intensity Map)

6.12.Forecast Impact Factors

7. Eastern Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

7.5.1. Diffusion Controlled Release System

7.5.2. Dissolution Controlled Release System

7.5.3. Osmotically Controlled Release System

7.5.4. Dissolution & Diffusion Controlled Release System

7.5.5. Ion Exchange Resins Controlled Release

7.5.6. Hydro-dynamically balanced drug delivery system

7.5.7. Others

7.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

7.6.1. Diffusion Controlled Release System

7.6.2. Dissolution Controlled Release System

7.6.3. Osmotically Controlled Release System

7.6.4. Dissolution & Diffusion Controlled Release System

7.6.5. Ion Exchange Resins Controlled Release

7.6.6. Hydro-dynamically balanced drug delivery system

7.6.7. Others

7.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

7.7.1. Solid Dosage Forms

7.7.2. Semisolid/Liquid/ Suspensions

7.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

7.8.1. Solid Dosage Forms

7.8.2. Semisolid/Liquid/ Suspension

7.9. Market Attractiveness Analysis

7.9.1. By Country

7.9.2. By Drug Release System

7.9.3. By Dosage Form

7.10.Key Representative Market Participants

7.11.Market Presence (Intensity Map)

7.12.Forecast Impact Factors

8. Asia Pacific excluding Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

8.3.1. China

8.3.2. India

8.3.3. ASEAN

8.3.4. Australia and New Zealand

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

8.4.1. China

8.4.2. India

8.4.3. ASEAN

8.4.4. Australia and New Zealand

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

8.5.1. Diffusion Controlled Release System

8.5.2. Dissolution Controlled Release System

8.5.3. Osmotically Controlled Release System

8.5.4. Dissolution & Diffusion Controlled Release System

8.5.5. Ion Exchange Resins Controlled Release

8.5.6. Hydro-dynamically balanced drug delivery system

8.5.7. Others

8.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

8.6.1. Diffusion Controlled Release System

8.6.2. Dissolution Controlled Release System

8.6.3. Osmotically Controlled Release System

8.6.4. Dissolution & Diffusion Controlled Release System

8.6.5. Ion Exchange Resins Controlled Release

8.6.6. Hydro-dynamically balanced drug delivery system

8.6.7. Others

8.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

8.7.1. Solid Dosage Forms

8.7.2. Semisolid/Liquid/ Suspensions

8.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

8.8.1. Solid Dosage Forms

8.8.2. Semisolid/Liquid/ Suspension

8.9. Market Attractiveness Analysis

8.9.1. By Country

8.9.2. By Drug Release System

8.9.3. By Dosage Form

8.10.Key Representative Market Participants

8.11.Market Presence (Intensity Map)

8.12.Forecast Impact Factors

9. Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

9.3.1. Diffusion Controlled Release System

9.3.2. Dissolution Controlled Release System

9.3.3. Osmotically Controlled Release System

9.3.4. Dissolution & Diffusion Controlled Release System

9.3.5. Ion Exchange Resins Controlled Release

9.3.6. Hydro-dynamically balanced drug delivery system

9.3.7. Others

9.4. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

9.4.1. Diffusion Controlled Release System

9.4.2. Dissolution Controlled Release System

9.4.3. Osmotically Controlled Release System

9.4.4. Dissolution & Diffusion Controlled Release System

9.4.5. Ion Exchange Resins Controlled Release

9.4.6. Hydro-dynamically balanced drug delivery system

9.4.7. Others

9.5. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

9.5.1. Solid Dosage Forms

9.5.2. Semisolid/Liquid/ Suspensions

9.6. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

9.6.1. Solid Dosage Forms

9.6.2. Semisolid/Liquid/ Suspension

9.7. Market Attractiveness Analysis

9.7.1. By Drug Release System

9.7.2. By Dosage Form

9.8. Key Representative Market Participants

9.9. Market Presence (Intensity Map)

9.10.Forecast Impact Factors

10. Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

10.1.Introduction

10.2.Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of MEA

10.4.Market Size (US$ Mn) Forecast By Country, 2017–2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of MEA

10.5.Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

10.5.1. Diffusion Controlled Release System

10.5.2. Dissolution Controlled Release System

10.5.3. Osmotically Controlled Release System

10.5.4. Dissolution & Diffusion Controlled Release System

10.5.5. Ion Exchange Resins Controlled Release

10.5.6. Hydro-dynamically balanced drug delivery system

10.5.7. Others

10.6.Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

10.6.1. Diffusion Controlled Release System

10.6.2. Dissolution Controlled Release System

10.6.3. Osmotically Controlled Release System

10.6.4. Dissolution & Diffusion Controlled Release System

10.6.5. Ion Exchange Resins Controlled Release

10.6.6. Hydro-dynamically balanced drug delivery system

10.6.7. Others

10.7.Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

10.7.1. Solid Dosage Forms

10.7.2. Semisolid/Liquid/ Suspensions

10.8.Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

10.8.1. Solid Dosage Forms

10.8.2. Semisolid/Liquid/ Suspension

10.9.Market Attractiveness Analysis

10.9.1. By Country

10.9.2. By Drug Release System

10.9.3. By Dosage Form

10.10. Key Representative Market Participants

10.11. Market Presence (Intensity Map)

10.12. Forecast Impact Factors

11. Forecast Factors: Relevance and Impact

12. Competition Landscape

12.1.Competition Dashboard

12.2.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

12.2.1. AstraZeneca Plc.

12.2.2. Bristol-Myers Squibb Company

12.2.3. Sun Pharmaceuticals Industries Ltd

12.2.4. Abbott Laboratories

12.2.5. Merck & Co. Inc.

12.2.6. Novartis AG

12.2.7. Pfizer Inc.

12.2.8. Mylan N.V.

12.2.9. Sanofi

12.2.10. F. Hoffman-La-Roche Ltd.

 12.2.11. Johnson & Johnson Services, Inc. 

12.2.12. Vectura Group plc. 

12.2.13. GlaxoSmithKline plc. 

13. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Region

13.1.Introduction/Key Findings

13.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

13.2.1. North America

13.2.2. Latin America

13.2.3. Western Europe

13.2.4. Eastern Europe

13.2.5. Asia Pacific excluding Japan

13.2.6. Japan

13.2.7. Middle East & Africa

13.3.Market Size (US$ Mn) Forecast By Region, 2017–2027

13.3.1. North America

13.3.2. Latin America

13.3.3. Western Europe

13.3.4. Eastern Europe

13.3.5. Asia Pacific excluding Japan

13.3.6. Japan

13.3.7. Middle East & Africa

13.4.Market Attractiveness Analysis By Region

14. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Release Systems Type

14.1.Introduction/Key Findings

14.2.Historical Market Size (US$ Mn) Trend Analysis By Drug Release Systems , 2012–2016

14.2.1. Diffusion Controlled Release System

14.2.2. Dissolution Controlled Release System

14.2.3. Osmotically Controlled Release System

14.2.4. Dissolution & Diffusion Controlled Release System

14.2.5. Ion Exchange Resins Controlled Release

14.2.6. Hydro-dynamically balanced drug delivery system

14.2.7. Others

14.3.Market Size (US$ Mn) Forecast By Drug Release Systems, 2017–2027

14.3.1. Diffusion Controlled Release System

14.3.2. Dissolution Controlled Release System

14.3.3. Osmotically Controlled Release System

14.3.4. Dissolution & Diffusion Controlled Release System

14.3.5. Ion Exchange Resins Controlled Release

14.3.6. Hydro-dynamically balanced drug delivery system

14.3.7. Others

14.4.Market Attractiveness Analysis By Drug Release Systems

15. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Dosage Form

15.1.Introduction/Key Findings

15.2.Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

15.2.1. Solid Dosage Forms

15.2.2. Semisolid/Liquid/ Suspension

15.3.Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

15.3.1. Solid Dosage Forms

15.3.2. Semisolid/Liquid/ Suspension

15.4.Market Attractiveness Analysis By Dosage

16. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

16.1.Market Size and Y-o-Y Growth

16.2.Absolute $ Opportunity

16.3.Market Value Chain

16.4.Forecast Impact Factors

17. Assumptions and Acronyms Used

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 02: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 03: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 04: Western Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 05: Western Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 06: Western Europe Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 07: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 08: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 09: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 10: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 11: Latin America Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 12: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 13: APEJ Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 14: APEJ Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 15: APEJ Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 16: Japan Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 17: Japan Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 18: Japan Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 19: MEA Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 20: MEA Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 21: MEA Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 22: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 23: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 24: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01 : North America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 02 : North America Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 03 : North America Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 04: North America Oral Solid Dosage Pharmaceuticals Historical Market Size and Y-o-Y, 2012 - 2016

Figure 05: North America Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y analysis, 2016 - 2027

Figure 06: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 07: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 08: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 09: Western Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 10: Western Europe Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 11: Western Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 12: Western Europe Oral Controlled Release Drug Delivery Technology Historical Market Size % Y-o-Y, 2012 - 2016

Figure 13: Western Europe Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) Y-o-Y analysis, 2016 – 2027

Figure 14: Western Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 15: Western Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 16: Western Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 17: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 18: Eastern Europe Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 19: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 20: Eastern Europe Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 – 2016

Figure 21: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 – 2027

Figure 22: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 23: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 24: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 25: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 26: Latin America Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 27: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 28: Latin America Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 – 2016

Figure 29: Latin America Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 – 2027

Figure 30: Latin America  Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 31: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 32: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 33: APEJ Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 34: APEJ Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 35: APEJ Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 36: APEJ Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis 2012 - 2016

Figure 37: APEJ Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 38: APEJ Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 39: APEJ  Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 40: APEJ Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 41 : Japan Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 42: Japan Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 43: Japan Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 44: Japan Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 45: Japan Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 46: Japan Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 47: MEA Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 48: MEA Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 49: MEA Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 50: MEA Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 51: MEA Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 52: MEA Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 53: MEA Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 54: MEA Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 55: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis, By Region

Figure 56: Global Oral  Controlled Release Drug Delivery Technology Market Attractiveness Analysis, By Drug Release System

Figure 57: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis, By Dosage Form

Figure 58: Global Oral Controlled Release Drug Delivery Technology Historical Market Size and Y-o-Y, 2012 - 2016

Figure 59: Global Oral Controlled Release Drug Delivery Technology Projected Market Size (US$ Mn) and Y-o-Y, 2017 – 2027

Figure 60: Global Oral Controlled Release Drug Delivery Technology Market Absolute $ Opportunity, 2012–2027

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Oral Controlled Release Drug Delivery Technology Market